秋水仙碱及其天然类似物(–)-N-乙酰秋水酚甲醚的不对称合成

doi:10.6023/cjoc202206034

有机化学 ›› 2023, Vol. 43 ›› Issue (1): 313-319.DOI: 10.6023/cjoc202206034 上一篇下一篇

研究简报

秋水仙碱及其天然类似物(–)-N-乙酰秋水酚甲醚的不对称合成

濮留洋^†^,^a^,^b^,^c, 李芷悦^†^,^b^,^c, 李利民^b^,^c, 马玉翠^b^,^c, 马民^a^,^*(), 胡胜全^b^,^c^,^*(), 吴正治^b^,^c^,^*()

a 暨南大学中西医结合博士后流动站广州 510632
b 深圳市转化医学研究院深圳市第二人民医院深圳大学第一附属医院广东深圳 518035
c 深圳市老年医学研究所广东深圳 518035

收稿日期:2022-06-20 修回日期:2022-07-26 发布日期:2022-09-01
通讯作者: 马民, 胡胜全, 吴正治
作者简介:
^† 共同第一作者
基金资助:
深圳市科技计划(JSGG20210901145539016); 深圳市科技计划(JCYJ20190812171005713); 深圳市科技计划(JCYJ20210324121611032); 深圳市宝安中医药发展基金会(2020KJCX-KTYJ-215); 深圳市优秀科技创新人才培养-博士启动(RCBS20210706092212002); 广东省基础与应用基础研究基金(2020A1515011427); 广东省基础与应用基础研究基金(2022A1515011777)

Asymmetric Synthesis of (–)-Colchicine and Its Natural Analog (–)-N-Acetylcolchicine Methyl Ether

Liu-Yang Pu^†^,^a^,^b^,^c, Zhiyue Li^†^,^b^,^c, Limin Li^b^,^c, Yucui Ma^b^,^c, Min Ma^a(), Shengquan Hu^b^,^c(), Zhengzhi Wu^b^,^c()

a Integrated Chinese and Western Medicine Postdoctoral Research Station, Jinan University, Guangzhou 510632
b Shenzhen Institute of Translational Medicine, Shenzhen Second People’s Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong 518035
c Shenzhen Institute of Geriatrics, Shenzhen, Guangdong 518035

Received:2022-06-20 Revised:2022-07-26 Published:2022-09-01
Contact: Min Ma, Shengquan Hu, Zhengzhi Wu
About author:
^† These authors contributed equally to this work.
Supported by:
Shenzhen Science and Technology Innovation Commission(JSGG20210901145539016); Shenzhen Science and Technology Innovation Commission(JCYJ20190812171005713); Shenzhen Science and Technology Innovation Commission(JCYJ20210324121611032); Shenzhen Baoan Chinese Medicine Development Foundation(2020KJCX-KTYJ-215); Shenzhen Excellent Scientific and Technological Innovation Talents Training Project-PhD Initiation Program(RCBS20210706092212002); Guangdong Basic and Applied Basic Research Foundation(2020A1515011427); Guangdong Basic and Applied Basic Research Foundation(2022A1515011777)

文章分享

1. 313.pdf(1082KB)

摘要/Abstract

采用相对简单的不对称合成方法, 完成了秋水仙碱及其天然类似物(–)-N-乙酰秋水酚甲醚(NCME)的形式全合成. 首先经简单醛、酮的Aldol缩合完成碳骨架的构筑, 然后经手性亚磺酰胺诱导的不对称还原胺化反应, 廉价、高效地合成了手性胺中间体; 再经过高价碘试剂的氧化关环, 构筑该类生物碱的三元环结构. 本策略为该类生物碱的简便、快速合成提供了有效方法.

关键词: 秋水仙碱, (–)-N-乙酰秋水酚甲醚, 叔丁基亚磺酰胺, 不对称合成

(–)-Colchicine and its natural analogue (–)-N-acetylcolchinol methyl ether have been synthesized in a com- paratively conciser asymmetric synthetic approach. Firstly, the carbon framework was constructed by Aldol condensation of simple aldehydes and ketones, and then the chiral amine intermediates were synthesized economically and efficiently through asymmetric reductive amination with chiral tert-butanesulfinamide. The 3-rings skeleton of colchicine and related alkaloids was then constructed by oxidation with hypervalent iodine reagent. Our strategy provides an efficient method for the convenient and economical synthesis of these alkaloids.

Key words: colchicine, (–)-N-acetylcolchinol methyl ether, tert-butanesulfinamide, asymmetric synthesis

引用此文

濮留洋, 李芷悦, 李利民, 马玉翠, 马民, 胡胜全, 吴正治. 秋水仙碱及其天然类似物(–)-N-乙酰秋水酚甲醚的不对称合成[J]. 有机化学, 2023, 43(1): 313-319.

Liu-Yang Pu, Zhiyue Li, Limin Li, Yucui Ma, Min Ma, Shengquan Hu, Zhengzhi Wu. Asymmetric Synthesis of (–)-Colchicine and Its Natural Analog (–)-N-Acetylcolchicine Methyl Ether[J]. Chinese Journal of Organic Chemistry, 2023, 43(1): 313-319.

导出引用 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

分享此文

图/表 4

Figure 1. Molecular structures of colchicine 1 and natural allocolchicinoids 2 and 3

Scheme 1. Retrosynthetic analysis of (–)-colchicine

Scheme 2. Formal total synthesis of (–)-colchicine

Scheme 3. Formal total synthesis of (–)-N-acetylcolchinol methyl ether (NCME)

参考文献 16

[1]	Nerlekar, N.; Beale, A.; Harper, R. W. Med. J. Australia 2014, 201, 687. doi: 10.5694/mja14.00846
[2]	(a) Lu, Y.; Chen, J.; Xiao, M.; Li, W.; Miller, D. D. Pharm. Res. 2012, 29, 2943. doi: 10.1007/s11095-012-0828-z pmid: 35392778
	(b) Richter, M.; Boldescu, V.; Graf, D. K.; Streicher, F.; Dimoglo, A.; Bartenschlager, R.; Klein, C. D. ChemMedChem 2019, 14, 469. doi: 10.1002/cmdc.201800641 pmid: 35392778
	(c) Spartalis, M.; Tzima, I.; Anastasiou, A.; Spartalis, E.; Iliopoulos, D. C.; Siasos, G. Curr. Med. Chem. 2022, 29, 4477. doi: 10.2174/0929867329666220407095216 pmid: 35392778
[3]	(a) Narasaraju, T.; Tang, B. M.; Herrmann, M.; Muller, S.; Chow, V. T. K.; Radic, M. Front Pharmacol. 2020, 11, 870. doi: 10.3389/fphar.2020.00870
	(b) Karampoor, S.; Hesamizadeh, K.; Maleki, F.; Farahmand, M.; Zahednasab, H.; Mirzaei, R.; Banoun, H.; Zamani, F.; Hajibaba, M.; Tabibzadeh, A.; Bouzari, B.; Bastani, M. N.; Laali, A.; Keyvani, H. Int. Immunopharmacol. 2021, 100, 108137. doi: 10.1016/j.intimp.2021.108137
[4]	The Lancet Lancet 2022, 399, 1753. doi: 10.1016/S0140-6736(22)00817-0 pmid: 35526539
[5]	(a) Jackson, C. B.; Farzan, M.; Chen, B.; Choe, H. Nat. Rev. Mol. Cell Biol. 2022, 23, 3. pmid: 32142651
	(b) Hoffmann, M.; Kleine-Weber, H.; Schroeder, S.; Kruger, N.; Herrler, T.; Erichsen, S.; Schiergens, T. S.; Herrler, G.; Wu, N. H.; Nitsche, A.; Muller, M. A.; Drosten, C.; Pohlmann, S. Cell 2020, 181, 271. doi: S0092-8674(20)30229-4 pmid: 32142651
[6]	Lopes, M. I.; Bonjorno, L. P.; Giannini, M. C.; Amaral, N. B.; Menezes, P. I.; Dib, S. M.; Gigante, S. L.; Benatti, M. N.; Rezek, U. C.; Emrich-Filho, L. L.; Sousa, B. A. A.; Almeida, S. C. L.; Luppino Assad, R.; Veras, F. P.; Schneider, A.; Rodrigues, T. S.; Leiria, L. O. S.; Cunha, L. D.; Alves-Filho, J. C.; Cunha, T. M.; Arruda, E.; Miranda, C. H.; Pazin-Filho, A.; Auxiliadora-Martins, M.; Borges, M. C.; Fonseca, B. A. L.; Bollela, V. R.; Del-Ben, C. M.; Cunha, F. Q.; Zamboni, D. S.; Santana, R. C.; Vilar, F. C.; Louzada-Junior, P.; Oliveira, R. D. R. RMD Open 2021, 7, e001455.
[7]	For reviews, see:
	(a) Gracheva, I. A.; Shchegravina, E. S.; Schmalz, H. G.; Beletskaya, I. P.; Fedorov, A. Y. J. Med. Chem. 2020, 63, 10618. doi: 10.1021/acs.jmedchem.0c00222
	(b) Ghawanmeh, A. A.; Al-Bajalan, H. M.; Mackeen, M. M.; Alali, F. Q.; Chong, K. F. Eur. J. Med. Chem. 2020, 185, 111788. doi: 10.1016/j.ejmech.2019.111788
[8]	For synthesis of colcicine before 2004, see: Graening, T.; Schmalz, H.-G. Angew. Chem., Int. Ed. 2004, 43, 3230 and references therein. doi: 10.1002/anie.200300615
[9]	(a) Graening, T.; Bette, V.; Neudorfl, J.; Lex, J.; Schmalz, H.-G. Org. Lett. 2005, 7, 4317. pmid: 28959419
	(b) Chen, B.; Liu, X.; Hu, Y.-J.; Zhang, D.-M.; Deng, L.; Lu, J.; Min, L.; Ye, W.-C.; Li, C.-C. Chem. Sci. 2017, 8, 4961. doi: 10.1039/c7sc01341h pmid: 28959419
	(c) Liu, X.; Hu, Y.-J.; Chen, B.; Min, L.; Peng, X.-S.; Zhao, J.; Li, S.; Wong, H. N. C.; Li, C.-C. Org. Lett. 2017, 19, 4612. doi: 10.1021/acs.orglett.7b02224 pmid: 28959419
	(d) Hoffmann, R. W.; Schmalz, H.-G.; Koert, U.; Pierens, G. K. Chem. Sci. 2019, 10, 943. doi: 10.1039/C8SC90247J pmid: 28959419
	(e) Liang, X.; Li, L.; Wei, K.; Yang, Y.-R. Org. Lett. 2021, 23, 2731. doi: 10.1021/acs.orglett.1c00638 pmid: 28959419
[10]	Banwell, M. G. Pure Appl. Chem. 1996, 68, 539. doi: 10.1351/pac199668030539
[11]	Li, Y.; Ma, Z.; Xu, X. Chin. J. Org. Chem. 2020, 40, 3991. (in Chinese) doi: 10.6023/cjoc202006024
	(李颖, 马志强, 徐学涛, 有机化学, 2020, 40, 3991.) doi: 10.6023/cjoc202006024
[12]	(a) Colyer, J. T.; Andersen, N. G.; Tedrow, J. S.; Soukup, T. S.; Faul, M. M. J. Org. Chem. 2006, 71, 6859. pmid: 17221983
	(b) Tanuwidjaja, J.; Peltier, H. M.; Ellman, J. A. J. Org. Chem. 2007, 72, 626. pmid: 17221983
[13]	Kang, G. J.; Getahun, Z.; Muzaffar, A.; Brossi, A.; Hamel, E. J. Biol. Chem. 1990, 265, 10255. pmid: 2191947
[14]	Zarga, M. H. A.; Sabri, S. S.; Al-Tel, T. H.; Rahman, A.; Shah, Z.; Feroz, M. J. Nat. Prod. 1991, 54, 936. doi: 10.1021/np50076a002
[15]	(a) Davies, S. G.; Fletcher, A. M.; Roberts, P. M.; Thomson, J. E.; Yeung, A. J. Nat. Prod. 2019, 82, 2659. doi: 10.1021/acs.jnatprod.9b00595
	(b) Davies, S. G.; Fletcher, A. M.; Roberts, P. M.; Thomson, J. E.; Yeung, A. Tetrahedron 2019, 75, 130694. doi: 10.1016/j.tet.2019.130694
[16]	For selected papers, see: pmid: 19180172
	(a) Seganish, W. M.; DeShong, P. Org. Lett. 2006, 8, 3951. pmid: 19180172
	(b) Vorogushin, A. V.; Wulff, W. D.; Hansen, H. J. Tetrahedron 2008, 64, 949. doi: 10.1016/j.tet.2007.10.115 pmid: 19180172

秋水仙碱及其天然类似物(–)-N-乙酰秋水酚甲醚的不对称合成

Asymmetric Synthesis of (–)-Colchicine and Its Natural Analog (–)-N-Acetylcolchicine Methyl Ether

RichHTML

PDF

补充材料

可视化

摘要/Abstract

引用此文

分享此文

图/表 4

参考文献 16

相关文章 15

编辑推荐

相关统计

本文评价

[1]	王化坤, 任晓龙, 宣宜宁. 卤盐催化的α,β-环氧羧酸酯与异氰酸酯[3＋2]环加成反应研究[J]. 有机化学, 2024, 44(1): 251-258.
[2]	于士航, 刘嘉威, 安碧玉, 边庆花, 王敏, 钟江春. 黑腹尼虎天牛接触性信息素的不对称合成[J]. 有机化学, 2024, 44(1): 301-308.
[3]	张俊杰, 徐学涛. (S)-(–)-Xylopinine和(S)-(+)-Laudanosine的不对称合成[J]. 有机化学, 2023, 43(9): 3297-3303.
[4]	王玉超, 刘晋彪, 何智涛. 钯催化共轭二烯的不对称氢官能团化[J]. 有机化学, 2023, 43(8): 2614-2627.
[5]	宋亭谕, 李冉, 黄利华, 贾世琨, 梅光建. N—N单键阻转异构体的催化不对称合成[J]. 有机化学, 2023, 43(6): 1977-1990.
[6]	罗诚, 尹艳丽, 江智勇. P-手性膦氧化物的不对称合成研究进展[J]. 有机化学, 2023, 43(6): 1963-1976.
[7]	蒙玲, 汪君. 硫代黄烷酮类衍生物的合成研究进展[J]. 有机化学, 2023, 43(3): 873-891.
[8]	张怀远, 许诺, 唐蓉萍, 石星丽. 手性高价碘试剂诱导的不对称去芳构化反应研究进展[J]. 有机化学, 2023, 43(11): 3784-3805.
[9]	匡鑫, 丁昌华, 吴奕晨, 王鹏. 手性烯丙基硅烷的催化对映选择性合成[J]. 有机化学, 2023, 43(10): 3367-3387.
[10]	毛沅浩, 高延峰, 苗志伟. 过渡金属催化不对称环化反应合成七元环化合物研究进展[J]. 有机化学, 2022, 42(7): 1904-1924.
[11]	姚婷, 李佳燕, 王佳明, 赵常贵. 氮杂环卡宾催化构筑含七元环结构的研究进展[J]. 有机化学, 2022, 42(4): 925-944.
[12]	王立花, 公绪顺, 雷婷, 江世智. 黄烷酮的不对称合成研究进展[J]. 有机化学, 2022, 42(3): 758-769.
[13]	苏艺雯, 邹有全, 肖文精. 光催化去消旋化的研究进展[J]. 有机化学, 2022, 42(10): 3201-3212.
[14]	滕明瑜, 韩涛, 黄恩和, 叶龙武. 金属卡宾参与的对映选择性去对称化反应研究进展[J]. 有机化学, 2022, 42(10): 3295-3301.
[15]	成秀亮, 李冬, 杨博轩, 林玉妹, 龚磊. 手性Lewis酸催化的可见光不对称合成研究进展[J]. 有机化学, 2022, 42(10): 3335-3350.